Health and Fitness Health and Fitness
Wed, October 5, 2011
[ Wed, Oct 05th 2011 ] - Market Wire
Basilea receives request for extraordinary shareh .. lect additional members to the board of directors
[ Wed, Oct 05th 2011 ] - Market Wire
Waters Empowers Advantar Laboratories for Sustained Growth
[ Wed, Oct 05th 2011 ] - Market Wire
Investigational Oral Multiple Sclerosis Therapy T .. ignificantly Reduced Relapse Rate, Disability Pro
[ Wed, Oct 05th 2011 ] - Market Wire
MURRAY FRANK LLP Announces Investigation of Pharmaceutical Product Development, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of DaVita, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Voclosporin study published in the American Journal of Transplantation
[ Wed, Oct 05th 2011 ] - Market Wire
Inovio Pharmaceuticals' Synthetic Vaccine for Can .. ost Promising Research at Global Vaccine Congress
[ Wed, Oct 05th 2011 ] - Market Wire
OncoSec Releases Devices for Use in Clinical Trials
Tue, October 4, 2011
[ Tue, Oct 04th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Announces Inve .. ation of Pharmaceutical Product Development, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
POZEN Provides Patent Litigation and Financial Guidance Update
[ Tue, Oct 04th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates DaVita, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Ryan & Maniskas, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
[ Tue, Oct 04th 2011 ] - Market Wire
Investigation of Pharmaceutical Product Developme .. oldfarb Branham Law Firm LLP for Potential Shareh
[ Tue, Oct 04th 2011 ] - Market Wire
Neurocrine Biosciences Receives Second Milestone .. $20 Million Under Abbott Collaboration Agreement
[ Tue, Oct 04th 2011 ] - Market Wire
Initial Data from Bio-Path Holdingsa? Phase I Cli .. entation at American Society of Hematology Annual
Mon, October 3, 2011
[ Mon, Oct 03rd 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Inve .. tion of Pharmaceuticals Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results
[ Mon, Oct 03rd 2011 ] - Market Wire
Por segundo ao consecutivo, el Humana Walmart-Pre .. a prima mensual ms baja en los 50 estados y en Wa
[ Mon, Oct 03rd 2011 ] - Market Wire
Gentiva® Health Services Comments on Senate Finance Committee Report
[ Mon, Oct 03rd 2011 ] - Market Wire
Tomball Regional Medical Center Completes Sale to Subsidiary of Community Health Systems, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces I .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces Investigation of American Medical Alert Corp.
[ Mon, Oct 03rd 2011 ] - Market Wire
Tripp Levy PLLC Announces Investigation of Pharmaceutical Product Development
[ Mon, Oct 03rd 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Investigation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Annou .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Medwell Capital to Adopt IFRS
[ Mon, Oct 03rd 2011 ] - Market Wire
IMRIS Announces Retirement of Chief Operating Officer

IMRIS Announces Retirement of Chief Operating Officer


Published on 2011-10-03 13:13:33 - Market Wire
  Print publication without navigation


WINNIPEG, Oct. 3, 2011 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the retirement of the Company's Chief Operating Officer, Ed Richmond.

Mr. Richmond joined IMRIS in 2006 as Vice President of Operations and subsequently went on to be Executive Vice President Customer Solutions, before being appointed Chief Operating Officer in 2009.

Mr. Richmond's retirement is effective October 3, 2011.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.


Contributing Sources